Role of glutamate and excitotoxicity in human neurological disease;ROLE DU GLUTAMATE ET DE L'EXCITOTOXICITE DANS LES MALADIES NEUROLOGIQUES

Revue Neurologique

Volumn 152, Issue 4, 1996, Pages 239-248

  Hugon, J ^a,b   Vallat, J M ^b   Dumas, M ^b  

^a UNIVERSITY OF LIMOGES   (France)

^b LIMOGES UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMPA RECEPTOR; GLUTAMIC ACID; GUANINE NUCLEOTIDE BINDING PROTEIN; ION CHANNEL; KAINIC ACID RECEPTOR; METABOTROPIC RECEPTOR; N METHYL DEXTRO ASPARTIC ACID; GLUTAMATE RECEPTOR;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; HUNTINGTON CHOREA; HYPOGLYCEMIA; NERVE CELL DEGENERATION; NERVE CELL NECROSIS; NEUROLOGIC DISEASE; NEUROTRANSMISSION; PARKINSON DISEASE; PATHOPHYSIOLOGY; REVIEW; STROKE; ACUTE DISEASE; CHRONIC DISEASE; CLASSIFICATION; HUMAN; PHYSIOLOGY;

ACUTE DISEASE; CHRONIC DISEASE; GLUTAMIC ACID; HUMANS; NERVOUS SYSTEM DISEASES; RECEPTORS, GLUTAMATE;

EID: 0029996740     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (115)

1. BADING J., GINTY D.D., GREENBERG M.E., (1993). Regulation of gene expression in hippocampal neurons by distinct calcium signaling pathways. Science, 260 : 181-186.
2. BARINAGA M. (1995). A new face for the glutamate receptor. Science, 267 : 177-178.
3. BARNES J.M., HENLEY J.M. (1992). Molecular characteristics of excitatory amino acid receptors. Progress Neurobiol, 39 : 113-133.
4. BEAL M.F., KOWALL N.W., ELLISON D.W., MAZUREK M.F., SAWARTZ K.J., MARTIN J.B. (1986). Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid. Nature, 321 : 168-171.
5. BEAL M.F. (1992a). Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses? Ann Neurol, 31 : 119-130.
6. BEAL M.F. (1992b). Role of excitotoxicity in human neurological diseases. Current Opinion Neurobiol, 2 : 657-662.
7. BEN-ARI Y. (1985). Limbic seizures and brain damages produced by kainic acid : mechanisms and relevance to human temporal lobe epilepsy. Neuroscience, 14 : 375-403.
8. BENVENISTE H., DREJER J., SCHOUSBOE A., DIEMER N.H. (1984). Elevation of the extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis. J Neurochem, 43 : 1369-1374.
9. BERL S., LAJTHA A., WAELSCH H. (1961). Amino acid and protein metabolism. VI. Cerebral compartments of glutamic acid metabolism. J Neurochem, 7 : 186-197.
10. BLISS T.V.P., COLLINGRIDGE G.L. (1993). A synaptic model of memory : long-term potentiation in the hippocampus. Nature, 361 : 31-39.
11. BOUILLET E., JENKINS B.G., HYMAN B.T., FERRANTE R.J., KOWALL N.W., SRIVASTAVA R., SAMANTA ROY D., ROSEN D.R., BEAL M.F. (1993). Age-dependent vulnerability of the striatum to the mitochondrial toxin 3-nitropropionic acid. J Neurochem, 60 : 356-359.
12. BOUVIER M., SZATKOWSKI M., AMATO A., ATTWELL D. (1992). The glial cell glutamate uptake carrier countertransports pH-changing anions. Nature, 360 : 471-474.
13. BRENNEMAN D.E., WESTBROOK G.L., FITZGERALD S.P., ENNIST D.L., ELKINS K.L., RUFF M.R., PERT C.B. (1988). Neuronal cell killing by the envelope protein of HIV and its prevention by vasoactive intestinal peptide. Nature, 335 : 639-642.
14. BRUNO V., SCAPAGNINI U., CANONICO P.L. (1993). Excitatory amino acids and neurotoxicity. Funct Neurol, 8 : 279-292.
15. BUCHAM A.M., XUE D., HUANG Z.G., SMITH K.E., LESIUK H. (1991). Delayed AMPA receptor blockage reduces cerebral infarction induced by focal ischemia. Neuroreport, 2 : 473-476.
16. CHAN P.H., FISCHMAN R.A., LONGAR S., CHEN S., YU A. (1985). Cellular and molecular effects of polyunsturated fatty acids in brain ischemia and injury. Prog Brain Res, 63 : 227-235.
17. CHOI D.W. (1988). Glutamate neurotoxicity and diseases of the nervous system. Neuron, 1 : 623-634.
18. CHOI D.W. (1992). Excitotoxic cell death. J Neurobiol, 23 : no 9, 1261-1276.
19. CORSELLIS J.A.N., BRUTON C.J. (1983). Neuropathology of status epilepticus in humans. Adv Neurol, 34 : 129-139.
20. COURATIER P., HUGON J., SINDOU P., VALLAT J.M., DUMAS M. (1993). Cell culture evidence for neuronal degeneration in amyotrophic lateral sclerosis being linked to glutamate AMPA/Kainate receptors. Lancet, 341 : 265-268.
21. COURATIER P., SINDOU P., ESCLAIRE F., LOUVEL E., HUGON J. (1994). Neuroprotective effects of riluzole in ALS CSF toxicity. Neuroreport, 5 : 1012-1014.
22. COURATIER P., SINDOU P., TABARAUD F., DIOP A.G., SPENCER P.S., HUGON J. (1995). Modulation of tau neuronal expression induced by NMDA, non-NMDA and metabotropic glutamate receptor agonists. Neurodegeneration, 4 : 33-41.
23. COYLE J.T., SCHWARCTZ R. (1976). Lesion of striatal neurones with kainic acid provides a model for Huntington's chroea. Nature, 263 : 244-246.
24. CURTIS D.R., WATKINS J.C. (1960). The excitation and depression of spinal neurons by structurally-related amino acids. J Neurochem, 6 : 117-141.
25. DAWSON V.L., DAWSON T.M., LONDON E.D., BREDT D.S., SNYDER S.H. (1991). Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures. Proc Natl Acad Sci USA, 88 : 6368-6371.
26. DE BONI U., MCLACHLAN D.R. (1985). Controlled induction of paired helical filaments of the Alzheimer type in cultured human neurons by glutamate and aspartate. J Neuro Sci, 68 : 105-118.
27. DESHPANDE J.K., SIESJO B.K., WIELOCH T. (1987). Calcium accumulation and neuronal damage in the rat hippocampus following cerebral ischemia. J Cereb Blood Flow Metab, 7 : 89-95.
28. DIFAZIO M.C., HOLLINGSWORTH Z., YOUNG A.B., PENNEY J.B. Jr (1992). Glutamate receptors in the substantia nigra of Parkinson's disease brains. Neurology, 42 : 402-406.
29. DIOP A.G., LESORT M., ESCLAIRE F., SINDOU P., COURATIER P., HUGON J. (1994). Tetrodotoxin blocks HlV coat protein (gp120) toxicity in primary neuronal cultures. Neurosci Lett, 165 : 187-190.
30. 28K-containing neurons, and not HSP70-expressing neurons, are more resistant to HIV-1 envelope (gp120) toxicity in cortical cell cultures. J Neurosci Res (in press).
31. DODD P.R., SCOTT H.L., WESTPHALEN R.J. (1994). Excitotoxic mechanisms in the pathogenesis of dementia. Neurochem Int, 25 : 203-219.
32. DREJER J., BENVENISTE H., DIEMER N.H., SCHOUSBOE A. (1985). Cellular origin of ischemia-induced glutamate release from brain tissue in vivo and in vitro. J Neurochem, 45 : 145-151.
33. FADEN A.I., SIMON R.P. (1988). A potential role for excitotoxins in the pathophysiology of spinal cord injury. Ann Neurol, 23 : 623-626.
34. FADEN A.I., DEMEDIUK P., PANTER S.S., VINK R. (1989). The role of excitatory amino acids and NMDA receptors in traumatic brain injury. Science, 244 : 798-800.
35. FONNUM F. (1984). Glutamate : a neurotransmitter in mammalian brain. J Neurochem, 42 : no 1, 1-11.
36. GIULIAN D., WENDT E., VACA K., NOOMAN C.A. (1993). The envelope glycoprotein of human immunodeficiency virus type 1 stimulates release of neurotoxins from monocytes. Proc Natl Acad Sci USA, 90 : 2769-2773.
37. GREENAMYRE J.T., PENNEY J.B., YOUNG A.B., D'AMATO C.J., HICKS S.P., SHOULSON I. (1985). Alterations in L-glutamate binding in Alzheimer's and Huntington's disease. Science, 227 : 1496-1499.
38. 3H] glutamate binding. J Neurochem, 48 : 543-551.
39. HANSEN A.J. (1985). Effect of anoxia on ion distribution in the brain. Physiol Rev, 65 : 101-148.
40. HAYASHI T. (1952). A physiological study of epileptic seizures following cortical stimulation in animals and its application to human clinics. Jap J Physiol, 3 : 46-64.
41. HENNEBERRY R.C. (1992). Cloning of the genes for excitatory amino acid receptors. Bio Essays, 14 : 465-471.
42. HEYES M.P., BREW B., MARTIN A., MARKEY S.P., PRICE R.W., BHALLA R.B., SALAZAR A. (1991). Cerespinal fluid quinolinic acid concentrations are increased in acquired immune deficiency syndrome. Adv Exp Med Biol, 294 : 687-690.
43. HIROSE K., CHAN P.H. (1992). Blockade of glutamate excitotoxicity and its clinical applications. Neurochem Res, 18 : 479-483.
44. HIRSCH J.A., GIBSON G.E. (1984). Selective alteration of neurotransmitter release by low oxygen in vitro. Neurochem Res, 9 : 1039-1049.
45. HOLLMANN M., BOULTER J., MARON C., BEASLEY L., SULLIVAN J. et al. : (1993). Zinc potentiates agonist-induced currents at certain splice variants of the NMDA receptor. Neuron, 10 : 943-954.
46. HUGON J., LUDOLPH A., ROY D.N., SCHAUMBURG H.H., SPENCER P.S. (1988). Studies on the etiology and pathogenesis of motor neuron diseases. II. Clinical and electrophysiologic features of pyramidal dysfunction in macaques fed lathyrus sativus and IDPN. Neurology, 38 : 435-442.
47. HUGON J., TABARAUD F., RIGAUD M., VALLAT J.M., DUMAS M. (1989a). Glutamate dehydrogenase (GDH) and aspartate aminotransferase (AAT) in leucocytes of patients with motoneuron disease. Neurology, 39 : 956-958.
48. HUGON J., VALLAT J.M., SPENCER P.S., LEBOUTET M.J., BARTHE D. (1989b). Kainic acid induces actute and delayed neuronal damages in rat spinal cord. Neurosc Lett, 104 : 758-763.
49. HUGON J., VALLAT J.M. (1990). Abnormal distribution of phosphorylated neurofilaments in neuronal degeneration induced by kainic acid. Neurosc Lett, 119 : 45-48.
50. HUGON J., LUDOLPH A.C., SPENCER P.C., GIMENEZ ROLDAN S., DUMAS J.L. (1993). Studies on the etiology and pathogenesis of motor neuron diseases. III. Magnetic cortical stimulation in patients with lathyrism. Acta Neurol Scandi, 88 : 412-416.
51. HUGON J., DIOP A.G., SINDOU P., ESCLAIRE F., LESORT M., BARTHE D. (1994). Calbindin-containing neurons are more resistant to HIV envelope protein (gp120) toxicity. Neurology, 44 : 395-396.
52. HUGON J., SINDOU P., LESORT M., COURATIER P., ESCLAIRE F., YARDIN C. (1995). Modifications of phosphorylated tau immunoreactivity linked to excitotoxicity in neuronal cultures. IPSEN, Alzheimer's disease : Lessons from cell biology. K.S. Kosik, Y. Christen, D.J. Selkoe (Eds), 172-179.
53. THE HUNTINGTON'S DISEASE COLLABORATIVE GROUP (1993). A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell, 72 : 971-983.
54. JOHNSON I.W., ASCHER P. (1987). Glycine potentiates the NMDA response in cultured mouse brain neurons. Nature, 325 : 529-531.
55. JOHNSON G.A.R. (1973). Convulsions induced in 10-day old rats by intraperitoneal injections of monosodium glutamate and related excitant amino acids. Biochem Pharmacol, 22 : 137-140.
56. KAKU D.A., GOLDBERG M.P., CHOI D.W. (1991). Antagonism of Non-NMDA receptors augments the neuroprotective effect of NMDA receptor blockade in cortical cultures subjected to prolonged deprivation of oxygen and glucose. Brain Res, 554 : 344-347.
57. KOH J.Y., YANG L.L., COTMAN C.W. (1990). β-amyloid protein increases the vulnerability of cultured cortical neurons to excitotoxic damage. Brain Res, 533 : 315-320.
58. KREBS H.A. (1935). Metabolism of amino acids. IV. Synthesis of glutamine from glutamic acid and ammonia, and the enzymic hudrolysis of glutamine in animal tissue. Biochem J, 29 : 1951-1969.
59. LAFON-CAZAL M., PIETRI S., CULCASI M., BOCKAERT J. (1993). NMDA-dependent superoxide production and neurotoxicity. Nature, 364 : 535-537.
60. LAJTHA A., MAKER H.S., CLARKE D.D. (1981). Metabolism and transport of carbohydrates and amino acids. In : «Siegel G., Albers R.W., Agranoff B.W. et al. (Eds). Basic Neurochemistry». Little Brown & Co, Boston, p. 344.
61. LIPTON S.A, (1992). Models of neuronal injury in AIDS : another role for the NMDA receptor? Trends Neurosci, 15 : 75-79.
62. LIPTON S.A., ROSENBERG P.A. (1994). Excitatory amino acids as a final common pathway for neurological disorders. N Engl J Med, 330 : 613-622.
63. LUCAS D.R., NEWHOUSE J.P. (1957). The toxic effect of sodium L-glutamate on the inner layers of the retina. Arch Ophthalmol, 58: 193-204.
64. LUDOLPH A., HUGON J., DWIVEDI M.P., SCHAUMBURG H.H., SPENCER P.S. (1987). Studies on the etiology and pathogenesis of motor neuron diseases. Lathyrism : Clinical findings in established cases. Brain, 110 : 149-165.
65. LUDOLPH A.C., SEELIG M.O., LUDOLPH A., NOVITT P., ALLEN C.N., SPENCER P.S., SABRI M.I. (1992). 3-Nitropropionic acid decreases cellular energy levels and causes neuronal degeneration in cortical explants. Neurodegeneration, 1 : 21-28.
66. MACDONALD J.F., NOWAK L.M. (1991). Mechanisms of blockade of excitatory amino acid receptor channels. In : «The pharmacology of excitatory amino acids : TIPS special report, 25-29. D. Lodge, G. Collingridge (Ed)». Elsevier, Cambridge.
67. MALENKA R.C., NICOLL R.A. (1993). NMDA-receptor-dependent synaptic plasticity : multiple forms and mechanisms. TINS, 16 : 521-527.
68. MATTSON M.P., CHANG B., DAVIS D., BRYANT K., LIEBERBURG I., RYDEL R.E. (1992). β-amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J Neurosci, 12 : 376-389.
69. MCGEER E.G., MCGEER P.L. (1976). Duplication of biochemical changes of Huntington's chorea by intrastriatal injections of glutamic and kainic acids. Nature, 263 : 517-519.
70. MELDRUM B.S., GARTHWAITE J. (1990). Excitatory amino acid neurotoxicity and neurodegenerative disease. Trends Pharmacol Sci, 11 : 379-387.
71. MELDRUM B.S. (1993). Excitotoxicity and selective neuronal loss in epilepsy. Brain Pathol, 3 : 405-412.
72. MICHEL P.P., AGID Y. (1992). The glutamate antagonist, MK-801, does not prevent dopaminergic cell death induced by the 1-methyl-4-phenylpyridinium ion (MPP+) in rat dissociated mesencephalic cultures. Brain Res, 597 : 233-240.
73. MONYER H., GIFFARD R.G., HARTLEY D.M., DUGAN L.L., GOLDBERG M.P., CHOI D.W. (1992). Oxygen or glucose deprivation-induced neuronal injury in cortical cell cultures is reduced by tetanus toxin. Neuron, 5 : 967-973.
74. MOSINGER J.L., PRICE M.T., BAI H.Y., XIAO H., WOZNIAK D.F., OLNEY J.W. (1991). Blockade of both NMDA and Non-NMDA receptors is required for optimal protection against ischemic neuronal degeneration in the in vivo adult mammalian retina. Exp Neurol, 113 : 10-17.
75. NAKANISHI S., MASU M. (1994). Molecular diversity and functions of glutamate receptors. Annu Rev Biophys Biomol Struct, 23 : 319-348.
76. NOWAK L., BREGESTOVSKI P., ASCHER P. (1984). Magnesium gates glutamate-activated channels in mouse central neurones. Nature, 307 : 462-465.
77. O'CONNOR J.J., ROWAN J.R., ANWYL R. (1994). Long-lasting enhancement of NMDA receptor-mediated synaptic transmission by metabotropic glutamate receptor activation. Nature, 367 : 557-559.
78. OLNEY J.W. (1971a). Glulamate-induced neuronal necrosis in the infant mouse hypothalamus : An electron microscopic study. J Neuropathol Exp Neurol, 30 : 75-90.
79. OLNEY J.W., HO O.L., RHEE V. (1971b). Cytotoxic effects of acidic and sulphuer containing amino acids on the infant mouse central nervous system. Exp Brain Res, 14 : 61-76.
80. OLNEY J.W., FULLER T., DEGUBAREFF T. (1979). Acute dendrotoxic changes in the hippocampus of kainate-treated rats. Brain Res, 176 : 91-100.
81. PEILLET E.L., ARVIN B., MONCADA C., MELDRUM B.S. (1992). The Non-NMDA antagonists. NBQX and GYKI 52466, protect against cortical and striatal cell loss following transient global ischemia in the rat. Brain Res, 571 : 115-120.
82. PHELLEGRINI-GIAMPIETRO D.E., CHERICI G., ALESIANI M., CARLA V., MORONI F. (1988). Excitatory amino acid release from rat hippocampal slices as a consequence of free-radical formation. J Neurochem, 51 : 1960-1963.
83. PERL T.M., BEDARD L., KOSATSKY T., HOCKIN J.C., TODD E.C.D., REMIS R.S. (1990). An outbreak of toxic encephalopathy caused by eating mussels contaminated with domoic acid. New Eng J Med, 322 : 1775-1780.
84. PIN J.P., BOCKAERT J. (1995). Get receptive to metabotropic glutamate receptor. Curr Opi Neurobiol, 5 : 342-349.
85. PLAITAKIS A., CAROSCIO J.T. (1987). Abnormal glutamate metabolism in amyotrophic lateral sclerosis. Ann Neurol, 22 : 575-579.
86. 3H] MK-801 binding to the N-methyl-D-aspartate receptor-ion channel complex by L-glutamate, glycine and polyamines. J Neurochem, 15 : 830.
87. ROTHMAN S.M., OLNEY J.W. (1986). Glutamate and the pathophysiology of hypoxic-ischemic brain damage. Ann Neurol, 19 : 105-111.
88. ROTHSTEIN J.D., MARTIN L.J., KUNCL R.W. (1992). Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis. N Engl J Med, 326 : 1464-1468.
89. SAUER D. (1993). EAA receptors and excitotoxicity. DN & P, 6 : 88-94.
90. SAUTIÈRE P.E., SINDOU P., COURATIER P., HUGON J., WATTEZ A., DELACOURTE A. (1992). Tau antigenic changes induced by glutamate in rat primary culture model : a biochemical approach. Neurosc Let, 140 : 206-210.
91. SEEBURG P.H. (1993). The molecular biology of mammalian glutamate receptor channels. TINS, 16 : 359-365.
92. SHAW P.J. (1993). Excitatory amino acid receptors, excitotoxicity, and the human nervous system. Curr Opi Neurol Neurosurg, 6 : 414-422.
93. SHENG M., CUMMINGS J., ROLDAN L.A., JAN Y.N., JAN L.Y. (1994). Changing subunit composition of heteromeric NMDA receptors during development of rat cortex. Nature, 368 : 144-147.
94. SIMON R.P., SWAN J.H., GRIFFITHS T., MELDRUÙ B.S. (1984). Blockade of N-methyl-D-aspartate receptors may protect against ischemic damage in the brain. Science, 226 : 850-852.
95. SINDOU P., COURATIER P., BARTHE D., HUGON J. (1992). A dose dependent increase of tau immunostaining is produced by glutamate toxicity in primary neuronal cultures. Brain Res, 572 : 242-246.
96. SINDOU P., LESORT M., COURATIER P., YARDIN C., ESCLAIRE F., HUGON J. (1994). Glutamate increases tau phosphorylation in primary neuronal cultures from fetal rat cerebral cortex. Brain Res, 646 : 124-128.
97. SINDOU P., COURATIER P., ESCLAIRE F., YARDIN C., BOUSSEAU A., HUGON J. (1994). Prevention of HIV coat protein (gp120) toxicity in cortical cell cultures by riluzole. J Neurol Sci, 126 : 133-137.
98. SLADECZEK F., PIN J.P., RECASENS M., BOCKAERTS J., WEISS S. (1985). Glutamate stimulates inositol phosphate formation in striatal neurones. Nature, 317 : 717-719.
99. SLADECZEK F., RECASENS M., BOCKAERT J. (1988). A new mechanism for glutamate receptor action : phosphoinositide hydrolysis. TINS, 12 : 545-549.
100. SOMMER B., SEEBURG P.H. (1992). Glutamate receptor channels : novel properties and new clones. TIPS, 13 : 291-296.
101. SONSALLA P.K., ZEEVALK G.D., MANZINO L., GIOVANNI A., NICKLAS W.J. (1992). MK-801 fails to protect against the dopaminergic neuropathology produced by systemic MPTP in mice or intranigral MPP+ in rats. J Neurochem, 58 : 1979-1982.
102. SPENCER P.S., ROY D.N., LUDOLPH A., HUGON J., DWIVEDI M.P., SCHAUMBURG H.H. (1986). Lathyrism : evidence for role of the neuroexcitatory aminoacid BOAA. Lancet, 2 : 8515, 1066-1067.
103. SPENCER P.S., NUNN P.B., HUGON J., LUDOLPH A.C., ROBERTSON R.C., ROSS S.M., ROY D.N. (1987). Guam amyotrophic lateral sclerosis - Parkinsonism - Dementia linked to a plant excitant neurotoxin. Science, 237 : 517-522.
104. SPENCER P.S., KISBY G.E., ROSS S.M., ROY D.N., HUGON J., LUDOLPH A.C., NUNN P.B. (1993). Guam ALS-PDC : possible causes. Science, 262 : 825-826.
105. TAYLOR-ROBINSON S.D., WEEKS R.A., SARGENTONI J., MARCUS C.D., BRYANT D.J., HARDING A.E., BROOKS D.J. (1994). Evidence for glutamate excitotoxicity in Huntington's disease with proton magnetic resonance spectroscopy (letter). Lancet, 343 : 1170.
106. TURSKI L., BRESSLER K., RETTIG K.J., LOESCHMANN P.A., WACHTEL H. (1991). Protection of substantia nigra from MPP+ neurotoxicity by N-methyl-D-aspartate antagonists. Nature, 349 : 414-419.
107. UITTI R.J., CALNE D.B. (1993). Pathogenesis of idiopathic parkinsonism. Eur Neurol, 33 : 6-23.
108. VAN GELDER N.M., SIATITSAS I., MENIN I.C., GLOOR P. (1983). Feline generalized penicillin epilepsy : changes of glutamic acid and taurine parallel the progressive increase in excitability of the cortex. Epilepsia, 24 : 200-213.
109. WHETSELL, W.O., SHAPIRA N.A. (1993). Neuroexcitation, excitotoxicity and human neurological disease. Biology of disease, 68 : 372-387.
110. WIELOCH T. (1985). Hypoglycemia-induced neuronal damage pervented by an N-methyl-D-aspartate antagonist. Science, 230 : 681-683.
111. WITYK R.J., STERN B.J. (1994). Ischemic stroke : today and tomorrow. CRIT-CARE-Med, Iss : 22-28.
112. WONG E.H.F., KEMP J.A., PRIESTLY T., KNIGHT A.R., WOODRUFF G.N., IVERSEN L.L. (1986). The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist. Proc natl Acad Sci USA, 83 : 7104-7108.
113. WRATHALL J.R., TENG Y.D., CHOINIERE D., MUNDT D.J. (1992). Evidence that local non-NMDA receptors contribute to functional deficits in contusive spinal cord injury. Brain Res, 586 : 140-143.
114. WROBLEWSKI J.T., DANYSZ W. (1989). Modulation of glutamate receptors : molecular mechanisms and functional implications. Rev Pharmac, 29 : 441-474.
115. YOUNG A.B., GREENAMYRE J.T., HOLLINGSWORTH Z., ALBIN R., D'AMATO C., SHOULSON I., PENNEY J.B. (1988). NMDA receptor losses in putamen from patients with Huntington's disease. Science, 241 : 981-983.